# Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

> **NCT07443774** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 81 (estimated)

## Conditions studied

- ER+ Breast Cancer
- Breast Cancer
- Early Breast Cancer
- Endocrine Therapy
- Abemaciclib
- Ribociclib

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07443774
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2031-04
- **Final completion:** 2031-12
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07443774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07443774, "Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07443774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*